The 20 Best Undifferentiated Pleomorphic Sarcoma Doctors near Uniondale, NY

As Director of Quality and Patient Safety for Medical Oncology at the Monter Cancer Center, Dr. Tony Philip is committed to improving clinical outcomes. Board Certified in Hematology and Medical Oncology, Dr. Philip s clinical practice is solely dedicated to the treatment of patients with gastrointestinal cancers and sarcomas (cancers of the soft tissue and bone). He maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He participates in research focused on improving the care of patients with these diseases. Currently an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip completed his Hematology/Oncology fellowship at North Shore-LIJ and his internal medicine residency at Long Island Jewish Medical Center. Dr. Philip earned his MD at University at Buffalo School of Medicine and Biomedical Sciences. He is an active member of the American Society of Clinical Oncology, Connective Tissue Oncology Society, and American College of Physicians. Dr. Philip completed the Northwell Physician Leadership Development Program and the American Society of Clinical Oncology Quality Program. Dr. Philip is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, and Colorectal Cancer.

Dr. Laurent Ganry is an Academic Oral & Maxillofacial Surgeon (OMFS) with dual fellowship training in the USA, practicing Oncologic Head & Neck Surgery, Reconstructive Facial Surgery & Cosmetic Facial Procedure, and a third Fellowship training in Plastic surgery (Japan).He is an attending physician at the Long Island Jewish Medical Center in New York, USA, and an assistant professor at the Donal and Barbara Zucker School of Medicine at Hofstra/Northwell (Northwell Health).He earned his Medical Degree in OMFS at La Sorbonne University — College of Medicine, one of the top medical universities in Paris, France.Subsequently, he obtained Complementary Training in Facial Plastic Surgery and ENT / OMFS — Head and Neck Surgery in France, Japan, and the USA.He won Multiple Awards in Surgical Innovations and International Reconstructive Microsurgery Competitions, developed a medical device (Paten in the USA), and published over 30 scientific articles and book chapters, including one article in The Lancet Journal (one of the most prestigious medical journals).His scope of practice is:- Head and Neck Oncological Surgery - Reconstructive Facial Surgery - Benign Soft Tissue Tumors of the head and neck area- Benign Osseous Tumors and Cysts of the facial skeleton- Facial Trauma, Facial Paralysis, and Facial Sequels / Deformities Corrective Surgery- Facial Plastic Surgery (non-surgical & surgical)- Facial gender Affirming surgery. . His top areas of expertise are Basal Cell Skin Cancer, Tongue Cancer, Facial Paralysis, Bone Graft, and Osteotomy.

Corinne Liu is a Radiologist in Mineola, New York. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Metastatic Pleural Tumor, Lung Nodules, and Lymphofollicular Hyperplasia.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Laryngeal Cancer, Adenoid Cystic Carcinoma, Teratocarcinosarcoma, and Olfactory Neuroblastoma.

"Mansoor H. Beg, MD, is a surgical oncologist who joined Northwell Health's Department of Surgery in 1993. He specializes in cutaneous malignancies (cancer that begins in the outer layer of the skin) and both cancerous and noncancerous breast conditions. With 29 years of experience, Dr. Beg provides highly specialized care at Monter Cancer Center, where he treats newly diagnosed patients and those following up on their treatments.As part of a multidisciplinary team, Dr. Beg uses the most up-to-date techniques and technologies available to diagnose and treat malignant and benign conditions while minimizing discomfort and shortening recovery time. He works alongside medical oncologists, radiation oncologists, breast imaging technicians, plastic surgeons and geneticists to provide a holistic treatment plan complete with psychosocial support, physical therapy, occupational therapy and nutrition services as needed.Dr. Beg completed his residency in the Department of Surgery at North Shore University Hospital and his fellowship at Tulane University Hospital School of Medicine. Now, he is passionate about passing his knowledge on to the surgeons of the future as an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He takes part in daily resident education through the initial clinical experience (ICE) of first- and second-year medical students as well as the advanced clinical experience (ACE) of third-year students.In 2019, Dr. Beg received the Northwell Health Truly Award for Caring Touch for ""embodying compassion and having an exceptional caring touch and bedside manner."" He has also been selected as Teacher of the Year by Northwell Health Department of Surgery residents.A son of two physicians, Dr. Beg always knew he wanted to be a doctor. ""When I got to medical school, my mentors and clinical experiences attracted me to surgery,"" he explains. ""Then, my encounters with cancer patients drew me to surgical oncology. I knew I wanted to make a difference in their lives during such a scary time.""". Dr. Beg is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy.

Dr. Howard Goodman is Chief of the Musculoskeletal Oncology Service in the Orthopaedic Institute of Northwell Health and is an assistant professor at the Zucker School of Medicine at Hofstra / Northwell. His clinical practice includes benign and malignant tumors of the bones and soft tissue in the arms and legs, as well as treatment for bony metastatic disease.Dr. Goodman is a native New Yorker, and has spent his professional career caring for orthopaedic tumor patients in New York City and Long Island. He earned a bioengineering degree with honors from the University of Pennsylvania, his medical degree from the Albert Einstein College of Medicine, trained in Orthopaedics at Maimonides Medical Center, where he served as chief resident for a year and a half, and did postgraduate training in Musculoskeletal Oncology and Limb Salvage Surgery at UMDNJ New Jersey Medical School.Dr. Goodman is active with Northwell Cancer Institute initiatives, including running the multidisciplinary Sarcoma / Bone & Soft tissue Tumor Board. He has organized and run an annual Orthopaedic Pathology review course for the residents. He is on the faculty of 3 orthopaedic residencies as well as fellowships in Orthopaedic Joint Reconstruction, General Surgical Oncology and PMR Oncology Rehabilitation. Dr. Goodman has written multiple articles and book chapters and serves as a journal editor for orthopaedic oncology. He is a fellow of the American Academy of Orthopaedic Surgeons, and a member of the Musculoskeletal Tumor Society, International Skeletal Society, International Society of Limb Salvage Surgery and the New York Society of Orthopaedic Surgeons.Dr. Goodman s practice centers around patient based individualized care, with both operative and nonoperative considerations. He is involved in developing new surgical techniques and 3D printed anatomic models, instruments and implants. He believes in combining biologic with implant reconstruction options for allowing best outcomes for his patients. He has been listed as a Castle Connolly Top Doctor for more than 5 years. Dr. Goodman is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Chondroma, Fibrosarcoma, Osteochondroma, Bone Tumor, and Hip Replacement.

Danielle Bello is a Surgical Oncologist in Uniondale, New York. Dr. Bello has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Acrospiroma, and Bone Tumor. Dr. Bello is currently accepting new patients.

Anne Vinokur is a Radiation Oncologist in Garden City, New York. Dr. Vinokur is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Breast Cancer, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, and Adult Soft Tissue Sarcoma.

Samuel Kenan is an Orthopedics provider in Garden City, New York. Dr. Kenan is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Osteochondroma, Bone Tumor, Juvenile Angiofibroma, Ewing Sarcoma, and Hip Replacement.

Rachelle Goldfisher is a Pediatric Radiologist and a Radiologist in New Hyde Park, New York. Dr. Goldfisher is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Gas Bloat Syndrome, Megalencephaly-Capillary Malformation Syndrome, Perlman Syndrome, and Simpson-Golabi-Behmel Syndrome.

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Tissue Biopsy, and Thyroidectomy.

Francisco Garcia is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Garcia is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Alpha Thalassemia, Alpha Thalassemia X-Linked Intellectual Disability Syndrome, Thalassemia, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.

"Charles Carmine Conte, MD, is a surgical oncologist with over three decades of experience. He specializes in every type of cancer, including breast cancer, gastrointestinal cancers and melanoma. Joining Northwell in 2004, Dr. Conte sees patients at Northwell Health Physician Partners Surgical Oncology at Lake Success, part of Monter Cancer Center.""Cancer doesn't follow any rules-every case is unique and complex,"" says Dr. Conte. ""That's why we take a comprehensive approach for each patient. We have surgeons, medical oncologists and radiation oncologists, as well as access to many diagnostic tools and clinical trials, all at this one center."" He is also affiliated with many Northwell hospitals for his patients' convenience.Dr. Conte trained at institutions across the Northeast, attending medical school at Dartmouth and completing a residency at Hartford Hospital and a fellowship at Roswell Park Cancer Institute. He is an associate professor of surgery at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and teaches surgical oncology residents at Northwell. ""I really enjoy teaching because students and residents are always questioning things,"" he says. ""Explaining my decisions to them helps keep me sharp as a doctor.""When it comes to his patients, Dr. Conte is passionate about delivering personalized care. ""I love the challenge of putting the best plan together for each individual person,"" he says. ""Seeing the positive impact it has on their lives is very rewarding.""". Dr. Conte is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Intraductal Papilloma, Inflammatory Breast Cancer, Breast Infection, Lymphadenectomy, and Pancreatectomy.

"Matthew J. Weiss, MD, FACS, is deputy physician-in-chief and director of the surgical oncology program at Northwell Cancer Institute. He's a board-certified surgeon specializing in pancreas and liver diseases.With a relentless work ethic and strong desire to help people, Dr. Weiss always knew he wanted to be a doctor. ""I picked a field that allows me to tackle difficult problems and truly make an impact,"" he says.Dr. Weiss completed his residency in general surgery at Johns Hopkins Hospital and was dual fellowship trained in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center. He was previously chief of hepatobiliary surgery at Johns Hopkins, where he was also director of the Pancreas and Liver Multidisciplinary Clinics and the complex general surgical oncology fellowship. He also performed the first robotic Whipple at Johns Hopkins University. Joining Northwell in 2019, Dr. Weiss created a multidisciplinary team of surgeons, medical and radiation oncologists, geneticists, and other specialists who collaborate to create unique treatment plans for patients across the health system. ""Every cancer is different, and every patient is different,"" he says. ""Communication among multiple providers is the best way to ensure you're treating the entire person, properly,"" he says. Dr. Weiss's team also works with scientists from Cold Spring Harbor Laboratory and Feinstein Institutes for Medical Research to develop and run groundbreaking clinical trials. An international leader in both liver and pancreas surgery, Dr. Weiss has authored over 250 peer-reviewed publications in the field, and he's currently a professor of surgery and oncology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. ""Understanding both the science of the disease and the technological aspect of surgery is so important,"" he says. Dr. Weiss focuses on using cancer genetics to help find the right surgical approach for patients. When possible, he operates robotically using small incisions for faster healing, so patients don't have to wait as long to receive additional therapies that can improve outcomes. With recent advancements in the field, Dr. Weiss has been able to successfully perform high-risk surgeries that were turned down by other institutions. ""Being a surgeon is a tremendous responsibility, and I don't take it lightly,"" he says. ""I truly and deeply care about my patients and their families-I get to know them as people and am there throughout their entire journey. That's what I'm most proud of as a doctor.""". Dr. Weiss is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Hepatectomy.

Alan Kadison is a Surgical Oncologist in Lake Success, New York. Dr. Kadison is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Breast Lump, Intraductal Papilloma, Giant Mammary Hamartoma, Subareolar Abscess, and Lymphadenectomy.

Sepideh Gholami is a Surgical Oncologist in Lake Success, New York. Dr. Gholami is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Familial Colorectal Cancer, Hepatectomy, and Pancreaticoduodenectomy.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy.

Kit Cheng, MD, is the Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she is committed to the recruitment and education of future generations of physicians. Board certified in Internal Medicine, Hematology and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As an attending physician based at the Monter Cancer Center, Dr. Cheng specializes in breast cancer and gynecology oncology, namely cervical cancer, endometrial cancer, ovarian cancer, uterine cancer and vaginal cancer. She is a principal investigator and sub principal investigator in multiple breast and gynecologic oncology clinical trials. She maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Cheng earned her medical degree at the State University of New York at Buffalo. She trained in Internal Medicine and Hematology/Oncology at North Shore University Hospital where she was also Chief Fellow. Dr. Cheng is an active member of the American Society of Clinical Oncology and is fluent in Cantonese and English. Dr. Cheng is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.